• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 与良性前列腺增生——综述

Vitamin D and benign prostatic hyperplasia -- a review.

作者信息

Espinosa Geovanni, Esposito Ralph, Kazzazi Amir, Djavan Bob

机构信息

New York University School of Medicine, New York, NY, USA.

出版信息

Can J Urol. 2013 Aug;20(4):6820-5.

PMID:23930605
Abstract

INTRODUCTION

Benign prostatic hyperplasia (BPH) is a more common form of lower urinary tract symptoms (LUTS). BPH is due to the excessive growth of both stromal and epithelial cells of the prostate. Fifty percent of men over the age of 50 will have this disease, along with the probability that 90% of men at the age of 80 will have an enlarged prostate. The prevalence of vitamin D deficiency in the male urological population may represent a connection between BPH and vitamin D.

MATERIAL AND METHODS

This review is geared to provide the most relevant data on the correlation between vitamin D and BPH. A comprehensive review was conducted on all studies on the specific topic and compiled into a complete article.

RESULTS

Data suggests that vitamin D has an inhibitory effect on the RhoA/ROCK pathway, along with cyclooxygenase-2 expression and prostaglandin E2 production in BPH stromal cells. Increasing intake of vitamin D from diet and supplements has shown a correlation with decreased BPH prevalence. Vitamin D analogues of up to 6000 IU/day have shown to decrease prostate volume in BPH patients. Pre-clinical trials have shown vitamin D to not only decrease BPH cell and prostate cell proliferation alone, but also when induced by known growth promoting molecules such as IL-8, Des (1-3) IGF-1, testosterone and dihydrotestosterone. Among all the studies there has not been any side effects or negative implications with increased vitamin D intake.

CONCLUSION

The impact of vitamin D on prostate volume and BPH has shown promising results, thus proposing further studies on vitamin D and BPH be conducted.

摘要

引言

良性前列腺增生(BPH)是下尿路症状(LUTS)中较常见的一种形式。BPH是由于前列腺基质细胞和上皮细胞过度生长所致。50%的50岁以上男性会患此病,80岁男性中有90%可能会出现前列腺增大。男性泌尿系统人群中维生素D缺乏的患病率可能表明BPH与维生素D之间存在联系。

材料与方法

本综述旨在提供关于维生素D与BPH相关性的最相关数据。对所有关于该特定主题的研究进行了全面综述,并汇编成一篇完整的文章。

结果

数据表明,维生素D对BPH基质细胞中的RhoA/ROCK信号通路、环氧合酶-2表达和前列腺素E2生成具有抑制作用。从饮食和补充剂中增加维生素D的摄入量与BPH患病率降低相关。高达6000国际单位/天的维生素D类似物已显示可减小BPH患者的前列腺体积。临床前试验表明,维生素D不仅能单独降低BPH细胞和前列腺细胞的增殖,而且在已知的生长促进分子如IL-8、去(1-3)胰岛素样生长因子-1、睾酮和双氢睾酮诱导时也能降低其增殖。在所有研究中,增加维生素D摄入量均未出现任何副作用或负面影响。

结论

维生素D对前列腺体积和BPH的影响已显示出有前景的结果,因此建议对维生素D和BPH进行进一步研究。

相似文献

1
Vitamin D and benign prostatic hyperplasia -- a review.维生素 D 与良性前列腺增生——综述
Can J Urol. 2013 Aug;20(4):6820-5.
2
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.良性前列腺增生所致下尿路症状与性功能障碍关系的批判性分析。
Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29.
3
The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.维生素D受体激动剂依洛膦酸通过靶向RhoA/Rho激酶和NF-κB途径抑制白细胞介素-8依赖性良性前列腺增生基质细胞增殖和炎症反应。
Prostate. 2009 Apr 1;69(5):480-93. doi: 10.1002/pros.20896.
4
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.一种新型与良性前列腺增生相关的勃起功能障碍和下尿路症状的实验性大鼠模型:补充睾酮的自发性高血压大鼠。
BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.
5
Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia.维生素D缺乏作为良性前列腺增生的潜在标志物
Urology. 2016 Nov;97:212-218. doi: 10.1016/j.urology.2016.03.070. Epub 2016 Jun 17.
6
The role of combination medical therapy in benign prostatic hyperplasia.联合药物治疗在良性前列腺增生中的作用。
Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43. doi: 10.1038/ijir.2008.51.
7
The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial.维生素 D 补充对良性前列腺增生进展的影响:一项随机对照试验。
Clin Nutr. 2021 May;40(5):3325-3331. doi: 10.1016/j.clnu.2020.11.005. Epub 2020 Nov 7.
8
Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.度他雄胺可降低前列腺癌风险,从而改善良性前列腺增生的预后:度他雄胺减少前列腺癌事件(REDUCE)试验的二次分析。
Urology. 2011 Sep;78(3):641-6. doi: 10.1016/j.urology.2011.03.063. Epub 2011 Jul 20.
9
[Prevalence of benign prostatic hyperplasia in Pingliang, Gansu: investigation and clinical analysis].[甘肃平凉良性前列腺增生症患病率:调查与临床分析]
Zhonghua Nan Ke Xue. 2013 Apr;19(4):324-7.
10
Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.经计算的快速增长型良性前列腺增生——一种发生临床前列腺癌的风险因素。
Scand J Urol Nephrol. 2002;36(5):330-8. doi: 10.1080/003655902320783827.

引用本文的文献

1
The role of RhoA-ROCK signaling in benign prostatic hyperplasia: a review.RhoA-ROCK信号通路在良性前列腺增生中的作用:综述
Hum Cell. 2025 Feb 1;38(2):48. doi: 10.1007/s13577-025-01179-x.
2
Capsaicin reduces blood glucose and prevents prostate growth by regulating androgen, RAGE/IGF-1/Akt, TGF-β/Smad signalling pathway and reversing epithelial-mesenchymal transition in streptozotocin-induced diabetic mice.辣椒素通过调节雄激素、RAGE/IGF-1/Akt、TGF-β/Smad 信号通路以及逆转链脲佐菌素诱导的糖尿病小鼠中的上皮-间充质转化,降低血糖并抑制前列腺生长。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7659-7671. doi: 10.1007/s00210-024-03092-w. Epub 2024 May 3.
3
U-shaped association between serum 25-hydroxyvitamin D concentrations and urinary leakage among adult females aged 45 years and over in the United States: a cross-sectional study.
血清 25-羟维生素 D 浓度与美国 45 岁及以上成年女性尿失禁的 U 型关联:一项横断面研究。
BMC Womens Health. 2024 Jan 23;24(1):58. doi: 10.1186/s12905-024-02906-6.
4
Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome.良性前列腺增生概述:营养保健品中的膳食多酚、维生素和植物化学物质对前列腺微生物组的影响可缓解症状。
Int J Mol Sci. 2023 Mar 13;24(6):5486. doi: 10.3390/ijms24065486.
5
Beneficial Effects of the Very-Low-Calorie Ketogenic Diet on the Symptoms of Male Accessory Gland Inflammation.极低热量生酮饮食对男性附属腺体炎症症状的有益影响。
Nutrients. 2022 Mar 4;14(5):1081. doi: 10.3390/nu14051081.
6
An investigation on the relevance of prolactin, insulin-like growth factor-1 and 25-hydroxyvitamin D (25-OHD ) in canine benign prostatic hyperplasia in a predisposed breed model.犬良性前列腺增生易患品种模型中催乳素、胰岛素样生长因子-1 和 25-羟维生素 D(25-OHD)相关性的研究。
Vet Med Sci. 2021 Sep;7(5):1493-1503. doi: 10.1002/vms3.514. Epub 2021 May 20.
7
Prevalence, Burden, and Treatment of Lower Urinary Tract Symptoms in Men Aged 50 and Older: A Systematic Review of the Literature.50岁及以上男性下尿路症状的患病率、负担及治疗:文献系统评价
SAGE Open Nurs. 2018 Dec 26;4:2377960818811773. doi: 10.1177/2377960818811773. eCollection 2018 Jan-Dec.
8
Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study.胆钙化醇预防良性前列腺增生患者复发性尿路感染的随机对照研究。
World J Urol. 2019 Jul;37(7):1347-1352. doi: 10.1007/s00345-018-2536-8. Epub 2018 Oct 25.
9
Vitamin D deficiency and lower urinary tract symptoms in males above 50 years of age.50岁以上男性的维生素D缺乏与下尿路症状
Urol Ann. 2017 Apr-Jun;9(2):170-173. doi: 10.4103/0974-7796.204192.
10
Vitamin D and Urinary Incontinence among Korean Women: a Propensity Score-matched Analysis from the 2008-2009 Korean National Health and Nutrition Examination Survey.韩国女性中的维生素D与尿失禁:基于2008 - 2009年韩国全国健康与营养检查调查的倾向得分匹配分析
J Korean Med Sci. 2017 Apr;32(4):661-665. doi: 10.3346/jkms.2017.32.4.661.